1 Noonan JA. Noonan syndrome. An update and review for the primary pediatrician. Clin Pediatr (Phila). 1994;33(9):548–55.
2 Cessans C, Ehlinger V, Arnaud C, Yart A, Capri Y, Barat P, et al. Growth patterns of patients with Noonan syndrome: correlation with age and genotype. Eur J Endocrinol. 2016;174(5):641–50.
3 Noordam K, van der Burgt I, Brunner HG, Otten BJ. The relationship between clinical severity of Noonan’s syndrome and growth, growth hormone (GH) secretion and response to GH treatment. J Pediatr Endocrinol Metab. 2002;15(2):175–80.
4 Wingbermuehle E, Egger J, van der Burgt I, Verhoeven W. Neuropsychological and behavioral aspects of Noonan syndrome. Horm Res. 2009;72 Suppl 2:15–23.
5 Mendez HM, Opitz JM. Noonan syndrome: a review. Am J Med Genet. 1985;21(3):493–506.
6 Allanson JE. Noonan syndrome. J Med Genet. 1987;24(1):9–13.
7 Sharland M, Burch M, McKenna WM, Patton MA. A clinical study of Noonan syndrome. Arch Dis Child. 1992;67(2):178–83.
8 Nora JJ, Nora AH, Sinha AK, Spangler RD, Lubs HA. The Ullrich-Noonan syndrome (Turner phenotype). Am J Dis Child. 1974;127(1):48–55.
9 Marino B, Digilio MC, Toscano A, Giannotti A, Dallapiccola B. Congenital heart diseases in children with Noonan syndrome: An expanded cardiac spectrum with high prevalence of atrioventricular canal. J Pediatr. 1999;135(6):703–6.
10 Tajan M, Paccoud R, Branka S, Edouard T, Yart A. The RASopathy Family: Consequences of germline activation of the RAS/MAPK pathway. Endocr Rev. 2018;39(5):676–700.